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Summary
Purified CD3 -4 - thymocytes were obtained by depletion of CD3+ and CD4+ cells from fresh
thymocyte suspensions. 5-15% of these cells were found to express CD16 antigen, while other
natural killer (NK) cell markers were virtually absent. Double fluorescence analysis revealed that
20-40% of thymic CD16 + cells coexpressed CD1, while approximately half were cyCD3+ .
When cultured in the presence of peripheral blood lymphocytes and H9 leukemia cell line as
a source of irradiated feeder cells and interleukin 2 (I1,2), CD3 -4 - thymocytes underwent
extensive proliferation. In addition, after 1-2 wk of culture, 30-50% of these cells were found
to express CD16 surface antigen. Cloning under limiting dilution conditions of either CD3 -4`
or CD3 -4-16 - thymocytes in the presence of irradiated H9 cells resulted in large proportions
(ti50%) of CD16' clones. On the basis of the expression of surface CD16 and/or cyCD3
antigen, clones could be grouped in the following subsets: CD16'CYCD3+ ; CD16'cyCD3 -;
CD16-cyCD3+; and CD16 -cyCD3 -. All clones expressed CD56 surface antigen, displayed a
strong cytolytic activity against NK sensitive (K562) and NK-resistant (M14) target cells, and
produced IFN:y and tumor necrosis factor, but not 11,2. Similar to peripheral NK cells, thymic
CD16' cells expressed transcripts for CD16 and for CD3 e (Biassoni, R., S. Ferrini, I. Prigione,
A. Moretta, and E.O. Long. 1988.J. Rnmunol. 140:1685 .) and chains (Anderson, P., M. Caligiuri,
J. Ritz, and S.F. Schlossman. 1989. Natur e (Lond.]. 341:159). Therefore, it appears that cells that
are phenotypically and functionally similar to CD3 -CD16' NK cells may arise from immature
thymocytes.
t is a common notion that the thymus represents the pri-
mary site of T cell maturation while the CD3 -CD16'
NK cells derive from bone marrow precursors and do not
require the thymic environment for their maturation (1, 2).
Recent reports have suggested that the CD7'1 -3 -4 -8 -
thymocyte subset (containing the most immature thymocytes)
may not be uniquely composed of cells already committed
to the T cell lineage. For example, under appropriate culture
conditions, CD7'1 -3 -4 -8 - thymocytes were shown to be
capable of maturation into hematopoietic cells (1, 3). In the
present study, we demonstrate that CD16+ cells coex-
pressing cytoplasmic CD3 (cyCD3) or surface CD1 antigen
(typical thymocyte markers) are found within the CD7+
CD3 -4 - thymocyte population. Moreover, under appro-
priate culture conditions, a large fraction of clones derived
from CD3 -4- fresh thymocytes were characterized by the
CD3-CD16+CD56+ surface phenotype and a strong non-
MHC-restricted cytolytic activity.
Materials and Methods
Isolation of CD3 -4 - and CD3 - CD4 -CD16 - Human Thymo-
cytes. Normal human thymocytes were obtained from thymus frag-
ments removed during cardiac surgery of patients (2 mo to 4 yr
old), as described (4, 5). CD3-4- thymocyte populations were ob-
tained by depletion of CD3' 4' cells by the use of immunocoated
ox RBC and immunocoated magneticbeads as described (4). Both
cell purification steps were performed at 4°C. Cellsrecovered were
>99.9% CD3-4-. In some experiments, CD16' cells were fur-
ther removedby using immunomagnetic beads. The resulting cells
were >99.9% CD3-4-16 -.
Generation of Cell Lines Enriched in CD16' Cells from Human
Thymocytes. Highly purified CD3-4- or CD3-4 -16 - fresh
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with 10% FCS and 100 U/ml of rIL2 (Cetus Corp., Emeryville,
CA) in 96-well U-bottomedplates (Grenier, Nurtingen, FRG) con-
taining 105 irradiatedPBL either in the presence or in the absence
of 2 x 10' irradiated H9 or CEMK human T cell lines. In some
experiments, PHA (0.5%) or PMA (0.5 ng/ml) were added to the
culture. Cell growth was evident after 5-7 d of culture. High per-
centages (40-60%) of CD16' cells were found only in cell cul-
tures in which H9 tumor cells were present. Cells proliferated in
the presence of rIL2 for at least 4-6 wk.
Double Fluorescence Cytojluorometric Analysis.
￿
The techniques
used have been described in detail elsewhere (6). The mAbs used
included KDl (anti-CD16, ,y2A), OKT6 (anti-CD1, ,yl), and Leu-4
(anti-CD3, -yl). An anti-y2A FITC-conjugated goat anti-mouse
Ig and an anti-,yl PE-conjugated goat anti-mouse Ig (Southern
Biotechnology, Birmingham, AL) were used as second reagent.
Analysis of the expression of cytoplasmic CD3 antigen was per-
formed as described in detail elsewhere (4). Samples were run on
a FACStar® (Becton Dickinson & Co., Mountain View, CA), and
results are expressed as log green fluorescence intensity (x-axis) vs.
log red fluorescence intensity (y-axis).
Cloning of CD3- 4 - or CD3- 4- 16 - Thymocytes.
￿
Cloning of
highly purified CD3-4- or CD3 - 4- 16 - thymocytes was per-
formed under limiting dilution conditions as previously described
(7) in RPMI 1640 (Biochron, Berlin, FRG) plus 10% FCS sup-
plemented with 100 U/ml of rIL2. Microcultures contained, as
feeder cells, 105 irradiated PBL either in the presence or in the ab-
sence of irradiated H9 tumor cell line (2 x 10' cells/well). Evi-
dent cell growth could be detected after 12-18 d of culture. Clones
were further maintained in culture for 2-4 wk.
Functional Analysis. Cytolytic activity of thymocyte clones
against NK-sensitive (K562) and NK-resistant (M14) target cells
was tested in a 4-h "Cr release assay, as previously described in
detail (6). In the redirected killing assay, we used P815 (FcyP,')
as target cells and anti-CD3 GT3A) or anti-CD16 (KDI) mAbs
and PHA, as described (4, 6). The production of TNF-a, IFN-y,
and IL2 by thymocyte clones was tested by enzyme immunoas-
says, as previously described (4).
Northern Blot and Slot Blot Analysis.
￿
RNA for Northern blot
analysis was prepared, size fractionated by electrophoresis in agarose
gels containing formaldehyde, blotted, and hybridized as described
(8). Cellular cytoplasmic RNA was prepared starting from 106
cells. Cells were washed once in cold PBS and resuspended in 45
F1 of 10 mM cold Tris, pH 7.5, 1 mM EDTA, and then lysedby
adding 5 pl of 5% NP-40, and mixedon ice for 5 min. The nuclei
were then pelleted, and 50 Pl of a freshly prepared solution com-
posed of 30 P1 of 20x SSC and 20 Ecl of 37% (wt/vol) formalde-
hyde were added to the supernatant. The mixture was incubated
at 60°C for 15 min, and 105 cell aliquots were spotted using a 15 x
SSC solution to a charged nylon membrane (Gene Screen Plus; New
England Nuclear, Boston, MA) using a microfiltration apparatus
(Bio Dot SF; BioRad Chemical Division, Richmond, CA). The
nylon membranes were UV exposed (Stratalinker 1800; Stratagene,
La Jolla, CA) . The slot-blots were prehybridized and hybridized
as described (8) . The probes used were a 0.7-kb EcoRI fragment
of CD3-y cDNA clone pj6T3y-2 (9), a 0.9-kb OxaNI/BamHI
fragment ofthe CD3-e cDNA clone pDJ4 (10), a 0.8-kbPstl frag-
ment of CD3-8 cDNA (derived from clone 25 kindly provided by
Dr. Tak Mak, Ontario Cancer Institute, Toronto, Canada), a 1.7-kb
XbaI/EcoRI fragment of the CD3-(' cDNA (11) and a 1.0-kb
EcoRI/HindIII fragment ofthe CD16cDNA FcyIII-2/NA-2 (12).
Blots were exposed to X-ray film using intensifying screens at
-70°C.
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Results and Discussion
Presence of CD16' Cells in the CD3 - 4' Thymocyte Popu-
lation. Immature thymocytes were obtained by depletion of
CD3+ and CD4' cells from fresh thymocyte suspensions.
The resulting cell populations represented 1-5% of the total
thymocytes and were composed of CD3 - 4 - 8 - cells. In ad-
dition, these cells expressed CD7 (90-100%), CD1(20-30%),
CD2 (60-80%), CD5 (50-70%), HLA class I (100%), and
HLA class II (5-15%) antigens. Analysis of NK cell surface
markers indicated that 5-15% of these cellsexpressed surface
CD16 antigen, whereas other NK cell markers (including
CD57, GL183, and EB6) (6) were absent or present in very
low amounts (CD56' cells were 0-5%). Finally, cyto-
plasmic staining with anti-CD3 mAbs (specific for CD3-e
chain) (13) revealed that 40-60% of these cells were
cyCD3' .
Thymic CD16' Cells Can Coexpress CD1 or cyCD3 An-
tigens. We next analyzed whether the CD16' cells present
in CD3 - 4 - thymocytes coexpressed markers of immature
T cells such as surface CD1 and cyCD3 antigens. Double
fluorescence and FACS® analysis revealed that 20-40% of
CD16' cells coexpressed surface CD1 (see Fig. 1 A).
Moreover, -50% of CD16' cells expressed cyCD3 antigen
(Fig. 1 B). It should be noted that, in the same series of ex-
periments, no cyCD3' cells could be detected in peripheral
blood-derived CD3 - CD16' NK cells used as control (Fig.
1 C). Thus, the coexpression ofCD1 and/or cyCD3 antigen
indicates that (at least some) CD16' NK cells present in
fresh thymus are phenotypically different from typical pe-
ripheral blood-derived NK cells, and suggests that they may
belong to immature thymocytes.
Growth of CD16' Cellsfrom CD3 - 4` Thymocytes Is In-
duced in the Presence ofH9 Cell Line. We further investigated
whether CD16' thymic cells could be expanded in vitro
under suitable culture conditions. To this end, we used as
starting population CD3 - 4 - thymocytes and tested their
ability to respond to different stimuli including PMA, PHA,
and IL-2. In addition, CD3 -4- thymocytes were cultured
in the presence of different (irradiated) feeder cells, including
normal PBL or tumor cell lines (alone or in various combi-
nations). Strong proliferative responses were observed when
CD3'4- thymocytes were cultured in the presence of an ex-
ogenous source ofIL2 and a mixture ofirradiated H9 tumor
cells and PBL as feeder cells. Under these culture conditions,
the cell number recovered after 3-4 wk was up to 100-fold
higher than the initial cell input. It is of note that already
after 1-2 wk in culture, cells were homogeneously CD56',
and 30-50% expressed CD16 surface antigen (datanot shown).
Moreover, double fluorescence analysis revealed that, at day
10 of culture, 10-20% of CD16' cells coexpressed cyto-
plasmic CD3 antigen, while no CD1' cells could be de-
tected (data not shown). It should be noted that in all cul-
ture conditions in which feeder cellsdid not include H9 cells,
CD16' cells were virtually absent .
Growth ofCD16' Cellsfrom CD3-4- 16 - Thymocyte Pre-
cursors. We next investigated whether CD16' cells could
be also obtained starting from CD3 - 4 - thymocytes that
Proliferation of CD3- CD16+ Cells from Human Thymocyte PrecursorsFigure 1.
￿
Expression ofsurface CD1
or cytoplasmic CD3 antigens by thymic
CD16+ cells. In these experiments, the
surface expression ofCD16 antigen has
been evaluated in combination withsur-
face CD1 (A) or cytoplasmic CD3 an-
tigen (B) in fresh CD3-CD4 - thymo-
cytes. In C, peripheral blood CD3-
cells are shown for comparison. Cells
were stainedwith KD1(anti-CD16) fol-
lowed by anti-,y2A FITC-conjugated
goat anti-mouse Ig, and with either
OKT6 (anti-CD1) or Leu-4 (anti-CD3)
mAb followed by anti-,yl PE-conjugated goat anti-mouse Ig. For cytoplasmic staining (B and C), cells were fixed and permeabilized before staining
with anti-CD3 mAb, as described (4). The contour plot was divided into quadrants representing unstained cells (lower left), cells with only red fluores-
cence (upper left), cells with both red and green fluorescence (upper right), and cells with only green fluorescence (lower right). Samples were analyzed
on a FACStar®, and results are expressed as log green fluorescence intensity vs. log red fluorescence.
CD16 (F=TC) CD16 (F=TC)
had been further depleted of CD16+ cells. The starting
population did not contain detectable CD16+ cells, as as-
sessed by FRCS® analysis. However, after 1-2 wk of culture,
under the culture conditions indicated above, 30-40% ofcells
expressed surface CD16 molecules (data not shown) .
Cloning of CD16+ Cellsfrom Thymus.
￿
Freshly isolated
CD3- CD4 - thymocytes were cloned under limiting dilu-
tion in the presence of rIIJ2 and irradiated PBL, either in
the presence or in the absence ofirradiatedH9 cells. The max-
imal clonal efficiency(-5% in several experiments), and op-
timal cell proliferation was detectable when irradiatedH9 cells
were added to the culture. More importantly, in all six ex-
periments performed in the presence of H9 cells, >50% of
clones were CD3- CD16+, whereas CD3+ clones were
<10% and the remaining (30-40%) were CD3 - CD16 - . In
contrast, low proportions (0-5%) of CD16+ clones were
obtained from CD3 - 4 - thymocytes cultured in the absence
of H9 cells (under these conditions, >80% of clones were
CD3 - CD16 - ). Importantly, also when CD16+ cells had
been removed from the starting CD3- 4 - thymocyte popu-
lations, approximately half of the resulting clones were
CD3 - CD16+ . These data provide further evidence that
NEG C133 CD56 CD16
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proliferating CD16+ thymic cells may derive from CD16-
thymocyte precursors. In these experiments, >300 clones have
been analyzed for CD3 and CD16 surface antigen expres-
sion. 28 of such clones have been further characterized for
the expression of cyCD3 and surface CD56 antigens.
On the basis of the expression of surface CD16 and/or of
cytoplasmic CD3 antigens, clones derived from CD3"4 -
thymocytes (depleted or not of CD16+ cells) can be grouped
in four different subsets (Fig. 2). Thus, -25% of all clones
coexpress surface CD16 and cyCD3 antigen (CD16+cyCD3+).
The remaining CD16+ clones lack detectable cyCD3 an-
tigen (CD16+cyCD3 - ). On the other hand, among CD16 -
clones, those displaying cyCD3 represent 10% of all clones
(CD16-cyCD3+), while the remaining are "double nega-
tive" (CD16 - cyCD3 - ) . It should be noted that, indepen-
dent on their surface phenotype, all clones expressed high
levels of CD56 antigen (Fig. 2).
Thymic CD16+ Cells Express Transcripts for CD16 andfor
CD3 e and r Chains. We next analyzed the expression of
CD3 and CD16 transcripts both in CD3 - 16+ and CD3 -
16 - cultured thymocyte populations (these populations con-
tained 10% and 20%, respectively, of cyCD3+ cells). CD3 -
CD16+cyCD3+
(DOUBLE POSITIVE)
CD16tcyCD3-
CD16-cyCD3-
(DOUBLE NEGATIVE)
CD16-cyCD3+
Figure 2. Surface phenotype of
clones derived from CD3-4- thymo-
cytes. Cells were stained with either one
of the following mAbs: Leu-4 (anti-
CD3), Leu-19 (anti-CD56) and KD1
(anti-CD16). Fluorescein-conjugated
goat anti-mouse Ig was used as a second
reagent. For cytoplasmic staining, cells
were fixed and permeabilizedbefore in-
cubation with anti-CD3 mAb, as de-
scribed (4). Note that, on the basis of
surface CD16 and cytoplasmic CD3 an-
tigen expression, four distinct types of
clones can be distinguished. The four
clones shown are RO.3/25 (double
positive), RO.6/50 (CD16+cyCD3 -),
RO.12/50(double negative), and RO.6/
100 (CD16-cyCD3+). They are repre-
sentativeof28clones thathavebeen ana-
lyzed for all the phenotypicmarkers in-
dicated.
WÀ Rà
R, lu16+ thymocyte populations expressed the transcripts for
CD16 or CD3 e and r, but not for CD3-y and -6 chains
(14) . On the other hand, the CD3 - 16 - populations ex-
pressed a similar pattern ofCD3 transcripts but did not ex-
press the CD16mRNA (Fig. 3A) . The CD3 - 16+ thymo-
cyte clone (termed 12H7), (homogeneously cyCD3+) was
further analyzed by slot-blot analysis . A pattern similar to
that of polyclonal CD3 - 16+ populations was observed for
the expression of transcripts for both CD16 and CD3 chains
(Fig. 3 B) .
Functional Analysis of Thymic CD16+ Cells.
￿
Analysis of
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cytolytic functions indicated that all clones derived from
CD3 - 4 - thymocytes efficiently lysed both NK-sensitive
(K562) and NK-resistant (M14) tumor target cells (Table
1) . In a redirected killing assay, using P815 target cells,
both CD16+cyCD3+ and CD16+cyCD3 - clones (but not
CD16 - clones) displayed a strong cytolytic activity in the
presence of anti-CD16 mAbs (Table 1) . This indicates that,
similar to peripheral CD3-CD16+ NK cells, CD16+
thymic cells also have a functional CD16-mediated activa-
tion pathway. Further analysis of lymphokine production in
response to either PHA alone or a combination ofPHA and
Proliferation of CD3- CD16+ Cells from Human Thymocyte Precursors
Figure 3 .
￿
Transcripts coding for CD3 and CD16 mol-
ecules in cultured CD3- thymocytes populations. In A,
total RNA (5 kg) was isolated from the following cell
populations : CD3- CD16+ or CD3 -CD16 - thymo-
cytes; the TCR-alf3+ Jurkat T cell line; the TCRy/S+
Peer T cellline ; and the BM21 lymphoblastoidB cell line.
Cells were treated as described in Materials and Methods
and hybridized with the indicated probes. The 18SrRNA
subunit, used as marker, is indicated. In B, aliquots of
cytoplasmic RNA corresponding to 105 cells were blotted
on Gene Screen Plus membranes. 12H7 is a CD3 -CD16+
cyCD3+ thymic clone .Table 1.
￿
Cytolytic Activity of Clones Derived from CD3- 4- Fresh Thomocytes
PMA showed that CD16+ thymic clones produced IFN-y
and TNF-a, but not IL-2 (data not shown).
In conclusion, our data demonstrate that CD16+ cells are
present in human thymus. At least a fraction of these cells
belong to a novel CD3 - thymocyte subset also expressing
cyCD3 molecules. It is possible that these cellsrepresent the
thymic precursors of the minor peripheral blood CD3+ T
cell subset expressing CD16 antigen (2). On the other hand,
they may represent cell precursors capable of differentiation
into either T or CD3-CD16 + cells. In addition, in vitro ex-
periments demonstrated that CD3 - 16+ proliferating cells
(phenotypically similar to peripheral blood-derived NK cells)
could be obtained from CD3-4- thymocyte precursors.
Moreover, cloning experiments showed that the precursors
of CD16+ cells are present in the CD16 - fraction of
CD3 - 4 - thymocytes. Whether these precursors require the
thymus environment for their normal differentiation in vivo,
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